MML Investors Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.79M | Sell |
9,200
-1,665
| -15% | -$345K | ﹤0.01% | 1618 |
|
|
2026
Q1 | $2.44M | Sell |
10,865
-1,817
| -14% | -$453K | 0.01% | 1210 |
|
|
2025
Q4 | $3.05M | Buy |
12,682
+1,941
| +18% | +$496K | 0.01% | 1149 |
|
|
2025
Q3 | $2.94M | Sell |
10,741
-1,654
| -13% | -$452K | 0.01% | 1109 |
|
|
2025
Q2 | $3.2M | Buy |
12,395
+1,011
| +9% | +$241K | 0.01% | 1014 |
|
|
2025
Q1 | $2.55M | Sell |
11,384
-84
| -0.7% | -$19.6K | 0.01% | 1046 |
|
|
2024
Q4 | $2.62M | Buy |
11,468
+2,771
| +32% | +$667K | 0.01% | 992 |
|
|
2024
Q3 | $2.12M | Buy |
8,697
+260
| +3% | +$58.1K | 0.01% | 1065 |
|
|
2024
Q2 | $1.61M | Buy |
8,437
+4,433
| +111% | +$899K | 0.01% | 1144 |
|
|
2024
Q1 | $793K | Sell |
4,004
-329
| -8% | -$60.3K | ﹤0.01% | 1544 |
|
|
2023
Q4 | $745K | Buy |
4,333
+948
| +28% | +$146K | ﹤0.01% | 1528 |
|
|
2023
Q3 | $501K | Sell |
3,385
-3,850
| -53% | -$696K | ﹤0.01% | 1637 |
|
|
2023
Q2 | $1.58M | Buy |
7,235
+857
| +13% | +$191K | 0.01% | 1007 |
|
|
2023
Q1 | $1.4M | Sell |
6,378
-4,150
| -39% | -$900K | 0.01% | 923 |
|
|
2022
Q4 | $2.19M | Buy |
10,528
+62
| +0.6% | +$13.6K | 0.01% | 792 |
|
|
2022
Q3 | $2.29M | Sell |
10,466
-2,097
| -17% | -$477K | 0.02% | 710 |
|
|
2022
Q2 | $2.63M | Sell |
12,563
-1,856
| -13% | -$395K | 0.02% | 647 |
|
|
2022
Q1 | $3.5M | Buy |
14,419
+1,040
| +8% | +$252K | 0.02% | 574 |
|
|
2021
Q4 | $3.48M | Sell |
13,379
-508
| -4% | -$132K | 0.03% | 554 |
|
|
2021
Q3 | $3.66M | Sell |
13,887
-517
| -4% | -$141K | 0.03% | 516 |
|
|
2021
Q2 | $3.55M | Sell |
14,404
-1,217
| -8% | -$256K | 0.03% | 501 |
|
|
2021
Q1 | $3.03M | Buy |
15,621
+24
| +0.2% | +$4.81K | 0.03% | 512 |
|
|
2020
Q4 | $3.31M | Sell |
15,597
-353
| -2% | -$70.4K | 0.04% | 417 |
|
|
2020
Q3 | $2.73M | Sell |
15,950
-318
| -2% | -$58.7K | 0.03% | 420 |
|
|
2020
Q2 | $3.12M | Sell |
16,268
-1,039
| -6% | -$170K | 0.04% | 368 |
|
|
2020
Q1 | $2.55M | Buy |
17,307
+902
| +5% | +$144K | 0.04% | 346 |
|
|
2019
Q4 | $2.54M | Buy |
16,405
+368
| +2% | +$53K | 0.04% | 417 |
|
|
2019
Q3 | $2.17M | Sell |
16,037
-3,553
| -18% | -$466K | 0.03% | 426 |
|
|
2019
Q2 | $2.39M | Buy |
19,590
+671
| +4% | +$74.3K | 0.03% | 428 |
|
|
2019
Q1 | $1.97M | Buy |
18,919
+14,020
| +286% | +$1.45M | 0.03% | 465 |
|
|
2018
Q4 | $558K | Buy |
4,899
+204
| +4% | +$21.9K | 0.01% | 851 |
|
|
2018
Q3 | $542K | Buy |
4,695
+1,780
| +61% | +$195K | 0.01% | 967 |
|
|
2018
Q2 | $302K | Buy |
2,915
+48
| +2% | +$4.86K | 0.01% | 1083 |
|
|
2018
Q1 | $282K | Sell |
2,867
-230
| -7% | -$21.7K | 0.01% | 1111 |
|
|
2017
Q4 | $262K | Buy |
3,097
+370
| +14% | +$30.6K | 0.01% | 1147 |
|
|
2017
Q3 | $210K | Buy |
+2,727
| New | +$209K | ﹤0.01% | 1191 |
|
Other funds holding RMD
MML Investors Services's RMD Position: Q2 2026 in Review
MML Investors Services reduced its ResMed (RMD) stake by 15% in Q2 2026, selling an estimated $345K and leaving 9,200 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1618.
MML Investors Services first reported a position in RMD in Q3 2017 and has held it in 36 quarters since. The position peaked at $3.66M in Q3 2021. 482 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- MML Investors Services held 9,200 shares of ResMed worth $1.79M as of Q2 2026.
- MML Investors Services sold 1,665 ResMed shares in Q2 2026, an estimated $345K.
- ResMed made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1618 holding.
- MML Investors Services first reported a position in ResMed in Q3 2017 and has held it in 36 quarters since.
- MML Investors Services's ResMed position peaked at $3.66M in Q3 2021.
- 482 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.